Monday, October 7, 2013
For the second time this year,
all market cap segments closed the quarter in the black. Large caps valued at
$5 billion and above gained ground for the fifth consecutive quarter. They
added 12%, and are up 46% year to date.
Large caps were led by Pharmacyclics
Inc., which gained 74% in 3Q13 to $138.26.